Showing 1 - 2 results of 2 for search 'A. Ulys', query time: 0.02s Refine Results
  1. 1
    Sunitinib in patients with metastatic renal cell carcinoma of intermediate and high risk groups – Lithuanian National Cancer Institute retrospective analysis

    Sunitinib in patients with metastatic renal cell carcinoma of intermediate and high risk groups – Lithuanian National Cancer Institute retrospective analysis by V. Urbonas, A. Zalimas, D. Dabkeviciene, A. Ulys, A. Matulevicius, F. Jankevicius, S. Jarmalaite

    Published 2020-11-01
    Get full text
    Article
  2. 2
    Efficacy and safety of darolutamide (DARO) in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) and a prostate-specific antigen doubling time (PSADT) >6 months

    Efficacy and safety of darolutamide (DARO) in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) and a prostate-specific antigen doubling time (PSADT) >6 mo... by M.W.H. Bögemann, N.D. Shore, T.L.J. Tammela, A. Ulys, E. Vjaters, S. Polyakov, M. Jievaltas, M. Luz, B. Alekseev, I. Kuss, M-A. Le Berre, A. Snapir, T. Sarapohja, K. Fizazi

    Published 2020-07-01
    Get full text
    Article

Search Tools: